All News

Research seeks to improve the impact of household-based HIV testing and the link to care by community HIV care providers.

In violation of law, state plan would reimburse pharmacies below the actual cost of dispensing prescriptions to Medicaid patients

Judy Sommers Hanson, PharmD, FAPhA, chats with Pharmacy Times about the important role that pharmacists can play in educating the public on B1 and methotrexate use.

President Donald Trump promises to tackle the nation’s opioid crisis with a recently-signed executive order launching a commission to fight drug addiction.

Scientists identify specific genes that cooperate with a well-known tumor suppressor gene.

Genes can interact with a tumor suppressor gene to prevent the development of breast, prostate, and skin cancer.

The smartphone hit the shelves recently.

Study identifies 2 immune system molecules that may play a key role in drug-resistance.

The cytokines interleukin 1 beta (IL1β) and tumor necrosis factor alpha (TNFα) help the spread of drug-resistant cancer.

The rheumatoid arthritis (RA) drug market is projected to reach approximately $28.5 billion by 2025.

Current treatment options for MS help limit relapses, but are unable to reverse the damage the disease has already caused.

Baby Boomer age group testing levels for hepatitis C virus remained very low.

According to the CDC head lice is the most common and least harmful infestation in the United States as healthcare providers treat about 12 million cases per year resulting in an estimated 1 billion dollars being spent on treatment costs.

More biosimilar approvals may lead to lower costs.

The Global Patient Safety Challenge on Medication Safety aims to address the weaknesses in health systems that lead to medication errors and the severe harm that results.

Study identifies potential Achilles heel of kinase-driven cancers.

Majority of patients were free from local recurrence after 1 year of reirradiation with an advanced form of proton therapy.

Top news of the day from across the health care landscape.

Small doses of apixaban reduced stroke risk in dialysis patients.

Using opioids before surgery seen to triple medical costs.

Heart failure and frequent hospitalization can increase risk of readmission among diabetes patients.

Sandoz HACk focuses on using digital health to improve access to healthcare.

Top news of the day from across the healthcare landscape.

The multiple sclerosis (MS) community eagerly awaited the March 28 FDA approval of ocrelizumab (Ocrevus) for treating relapsing and primary progressive forms of MS. -

Ocrelizumab (Ocrevus) granted FDA approval to treat 2 forms of MS.

Novel test demonstrates the benefits of exercise in individuals with neurological injuries and illnesses.

New tuberculosis cases have declined over the past 5 years, but new data show rates are up for TB/HIV coinfections.

The appearance of Zika virus in the United States has accelerated the search for a vaccine.